Aminoguanidine Improved the Angiogenesis Induced by Tissue Ischemia in Diabetic Mice

LIU Ying,DONG Li,KANG Li-na
DOI: https://doi.org/10.16439/j.cnki.1673-7245.2009.11.014
2009-01-01
Abstract:Objective Using a mouse hind limb ischemia model,we compared the ischemia-induced angiogenesis between diabetic and non-diabetic mice,and the effects aminoguanidine,an inhibitor of advanced glycation end products (AGEs),on angiogenesis in diabetic mice.Methods Experimental diabetic models were induced by injected with streptozotocin (STZ)[40 mg/(kg·d),Ip] in C57BL/6 mice.Two weeks after the establishment of diabetic model,diabetic mice were randomly to receive placebo(n=61)or aminoguanidine[200 mg/(kg·d) gavage,n=61) for 8 weeks.Tissue ischemia was obtained by ligation of left femoral artery.Capillary density was determined in the ischemic and non-ischemic limbs by CD31 staining at days 0,1,3,7,14 and 28 post-operatively.Results Compared with non-diabetic controls,diabetic mice had reduced microvascular density[(6.92±0.85) vs (9.21±1.64)/HP,P<0.01].7th day after ischemia,decreases in capillary density in the ischemic tissue was shown in diabetic and aminoguanidine treated diabetic mice[(1.09±0.06),aminoguanidine (1.13±0.02)vs control(1.26±0.06)/HP,P<0.05].Administration of aminoguanidine didn't significantly improved the attenuated increase of capillary density induced by tissue ischemia in diabetic mice until 14 days after operation[(1.24±0.07) vs (1.11±0.08),P<0.05].Conclusion Our present data demonstrate that the stunted increased angiogenesis was presented in diabetic mice following tissue ischemia,and this dysfuncion in diabetic mice can be partly improved by the administration of aminoguanidine.
What problem does this paper attempt to address?